LLY compared with ADCT: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ADCTADC Therapeutics SA

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ADCTADC Therapeutics SA

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ADCT

0 of 2at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26—▼−4.65%—

Oct 13 '26—▼−8.60%—

= impliedLLY realized, solidADCT realized, hatchedOne scale, both sides: full bar = 91%× = |realized| ÷ impliedSource: market data

Q2 FY26

±90.3%

▼−14.63%

×0.16

May 4 '26±23.0%▼−3.92%×0.17

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,361.10· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ADCTADC Therapeutics SA

1.64▼−4.77%· post 1.58· delayed

After hoursNov 5 '26delayed

Mkt cap$219.6MRevenue$19MQ2 FY26Revenue$71MFY24

Compare

After hoursNov 5 '26delayed

LLYELI Lilly & Co

ADCTADC Therapeutics SA

1,371.32▼−3.29%post 1,361.10delayed

Price

1.64▼−4.77%post 1.58delayed

$1.3T

Mkt cap

$219.6M

Q3 FY26$24.4B

Revenue

$19MQ2 FY26

FY25$65.2B

Revenue

$71MFY24

LLY1,371.32▼−3.29%vsADCT1.64▼−4.77%After hoursNov 5 '26delayed